Stefanie Brehmer

DNA methylation-based classification of central nervous system tumours

David Capper, David Jones, Martin Sill et al. · Nature · 2018 · 3.1K citations · Full text

Medicine, Molecular Genetics, Oncology +14

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Felix Sahm, Daniel Schrimpf, Damian Stichel et al. · The Lancet Oncology · 2017 · 854 citations · Full text

Medicine, Molecular Biology, Pathology +16

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 576 citations · Full text

Medicine, Oncology, Pharmacology +16

TERT Promoter Mutations and Risk of Recurrence in Meningioma

Felix Sahm, Daniel Schrimpf, Adriana Olar et al. · JNCI Journal of the National Cancer Institute · 2015 · 400 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O⁶-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock et al. · Journal of Clinical Oncology · 2016 · 197 citations

Medicine, Oncology, Pharmacotherapy +15